European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
MILAN, Italy, June 06, 2025 – Italfarmaco S.p.A. announced today that the…
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Company announcement no. 7/2025 In accordance with Article 19 (3) of the…